# Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis

> **NCT05432531** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Anti JAK1,2
- **DRUG:** Cyclophosphamid

## Key facts

- **NCT ID:** NCT05432531
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05432531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05432531, "Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05432531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*